Professor Tina Wong, MBBS, Ph.D
Professor Tina Wong is Head and Senior Consultant in the Glaucoma Service at the Singapore National Eye Centre (SNEC), Director of Clinical Translational Research and Head of the Ocular Therapeutics and Drug Delivery Research Group at the Singapore Eye Research Institute (SERI). She is Professor at DukeNUS Graduate Medical School and adjunct Professor at Department of Ophthalmology, Yong Loo Lin School of Medicine, NUS.
Prior to taking up her positions in Singapore, Professor Wong was a Wellcome Trust Vision Research Fellow and completed a PhD in Professor Sir Peng Khaw’s laboratory at the Institute of Ophthalmology, University College London. Her research culminated to the award of the Oxford Ophthalmological Congress Fould’s Trophy and the prestigious Moorfields Research Gold Medal.
Her research interests are in glaucoma surgery, ocular inflammation and fibrosis and the application of sustained drug delivery platforms for ophthalmology. Professor Wong is a leading expert and thought leader in glaucoma surgery wound healing. She has authored extensively in peer-reviewed publications in her research fields, authored books and book chapters.
Professor Wong has an entrepreneurial streak in her research. She holds several patents to her name and licensed one of the patents on sustained drug delivery for glaucoma, to a spin-off company, Peregrine Ophthalmic, of which she is co-founder. In 2014, Prof Wong together with her collaborators at NTU, were awarded the prestigious President’s Science and Technology Award for this work. She is currently preparing 2 further start-up companies from her research.
Professor Wong is involved in both local and international education programmes, courses and regularly presents at international meetings. She is an active member of the Associate Advisory Board of the World Glaucoma Association and founding President for the Glaucoma Association Singapore. Professor Wong is a recipient of the National Clinician Scientist Award for her work on novel drug delivery platforms for glaucoma, and the Distinguished Service Award at the Asia Pacific Academy of Ophthalmology for her extensive contributions to ophthalmology and research in glaucoma.
Michael Ho, Ph.D
Prior to joining NHIC, Michael was a Scientist with A*STAR’s IME for five years. As a scientist in the Biomedical Integrated Circuit group, his primary focus was on Medtech innovation, working closely with clinical partners in areas of miniaturised medical device innovation and development. Michael has led and developed close to ten implantable and wearable medical devices, in areas of diagnostic and interventional solutions. He was involved extensively throughout the Medtech development cycle, from identifying the clinical needs through to clinical trials. He was awarded two research grants, and has authored/co-authored more than 30 peer reviewed papers, one book chapter, and filed two patents.
Michael holds a Ph.D from the University of Newcastle, Australia and completed the postgraduate course from Singapore Stanford Biodesign Innovation Class in 2014.